Revvityvs.Thermo Fisher Scientific
RVTY vs TMO · both in Life science tools, part of the Medicine, pharma & life science value chain: Instruments, reagents and equipment for research, development and production.
Thermo Fisher Scientific is about 16× larger than Revvity by market cap; Thermo Fisher Scientific trades at the lower P/E (28.6 vs 52.6); year to date, Revvity leads (+16.1% vs −9.0%).
Side by side
| RVTY | TMO | |
|---|---|---|
| Market cap | $12.6B | $196B |
| Price | $112.29 | $527.05 |
| Today | −0.6% | +0.4% |
| Return YTD | +16.1% | −9.0% |
| Return 1Y | +9.7% | +22.4% |
| P/E | 52.6 | 28.6 |
| P/S | 4.3 | 4.3 |
| P/B | 1.8 | 3.8 |
Data as of 2026-07-11 · updates daily after U.S. close
The two companies
RevvityRVTY
Life science tools and diagnostics across newborn screening and research.
Full RVTY profile →Thermo Fisher ScientificTMO
American world leader in life science tools — instruments, reagents, consumables and contract manufacturing (Patheon) for research and pharma.
Full TMO profile →More comparisons in Life science tools
See where RVTY and TMO sit in the full Medicine, pharma & life science map — every segment from suppliers to end markets.Open the Life science value chain →